Flora Growth (FLGC, $0.26) has a new growth opportunity via Franchise Global Health acquisition
Flora Growth Corp. is beginning 2023 with a major acquisition. As 2022 ended, Flora completed the acquisition of Franchise Global Health. Franchise Global Health is a Canadian cannabis company with primary operations in Germany, and is the owner of the first German medical cannabis import and distribution license.
This acquisition potentially boosts Flora’s access to Germany’s cannabis market and over 1,200 pharmacies. Some estimate suggests that the German medical cannabis market will surpass $900 million by 2025. Even Franchise Global Health could possibly benefit from the deal, in its ability to meet growing demand. Franchise Global Health’s suppliers were only able to deliver around 4 kilos every 8 weeks when the company had a demand of over 100 kilos every month.
ZSTK in upward trend: price rose above 50-day moving average on August 19, 2026
ZSTK moved above its 50-day moving average on August 19, 2026 date and that indicates a change from a downward trend to an upward trend. In of 31 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on August 03, 2026. You may want to consider a long position or call options on ZSTK as a result. In of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for ZSTK just turned positive on July 28, 2026. Looking at past instances where ZSTK's MACD turned positive, the stock continued to rise in of 39 cases over the following month. The odds of a continued upward trend are .
The 10-day moving average for ZSTK crossed bullishly above the 50-day moving average on August 21, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Following a +19 3-day Advance, the price is estimated to grow further. Considering data from situations where ZSTK advanced for three days, in of 207 cases, the price rose further within the following month. The odds of a continued upward trend are .
Bearish Trend Analysis
The RSI Indicator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 50 cases where ZSTK's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ZSTK declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
ZSTK broke above its upper Bollinger Band on August 19, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for ZSTK entered a downward trend on August 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ZSTK’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.963) is normal, around the industry mean (3.525). P/E Ratio (0.000) is within average values for comparable stocks, (27.186). ZSTK's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.208). ZSTK has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.086). P/S Ratio (0.286) is also within normal values, averaging (16.512).
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ZSTK’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 78, placing this stock worse than average.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
Advertisement